DK0610446T3 - Syntetisk peptidspecificitet af antimyelin basic protein fra cerebrospinalvæske fra dissemineret sklerose - Google Patents
Syntetisk peptidspecificitet af antimyelin basic protein fra cerebrospinalvæske fra dissemineret skleroseInfo
- Publication number
- DK0610446T3 DK0610446T3 DK93908754T DK93908754T DK0610446T3 DK 0610446 T3 DK0610446 T3 DK 0610446T3 DK 93908754 T DK93908754 T DK 93908754T DK 93908754 T DK93908754 T DK 93908754T DK 0610446 T3 DK0610446 T3 DK 0610446T3
- Authority
- DK
- Denmark
- Prior art keywords
- mbp
- residues
- synthetic peptide
- cerebrospinal fluid
- basic protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002053799A CA2053799C (en) | 1991-10-22 | 1991-10-22 | Synthetic peptide specificity of anti-myelin basic protein from multiple sclerosis cerebrospinal fluid |
| PCT/CA1992/000448 WO1993008212A1 (en) | 1991-10-22 | 1992-10-15 | Synthetic peptide specificity of anti-myelin basic protein from multiple sclerosis cerebrospinal fluid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0610446T3 true DK0610446T3 (da) | 2003-07-14 |
Family
ID=4148603
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK93908754T DK0610446T3 (da) | 1991-10-22 | 1992-10-15 | Syntetisk peptidspecificitet af antimyelin basic protein fra cerebrospinalvæske fra dissemineret sklerose |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0610446B1 (no) |
| AT (1) | ATE236193T1 (no) |
| AU (1) | AU2750092A (no) |
| CA (1) | CA2053799C (no) |
| DE (1) | DE69232987T2 (no) |
| DK (1) | DK0610446T3 (no) |
| ES (1) | ES2196007T3 (no) |
| FI (1) | FI111050B (no) |
| NO (1) | NO310513B1 (no) |
| NZ (1) | NZ244807A (no) |
| RU (1) | RU2121850C1 (no) |
| WO (1) | WO1993008212A1 (no) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6252040B1 (en) * | 1991-10-22 | 2001-06-26 | The Governors Of The University Of Alberta | Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
| US5817629A (en) * | 1991-10-22 | 1998-10-06 | The Governors Of The University Of Alberta | Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
| HUT77047A (hu) * | 1994-10-25 | 1998-03-02 | Immulogic Pharmaceutical Corporation | Szklerózis multiplex kezelésére szolgáló készítmények és kezelések |
| US6251396B1 (en) | 1994-11-18 | 2001-06-26 | Neurocrine Biosciences, Inc. | Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein |
| US6329499B1 (en) * | 1994-11-18 | 2001-12-11 | Neurocrine Biosciences, Inc. | Methods for treatment of multiple sclerosis using peptide analogues of human myelin basic protein |
| US6379670B1 (en) | 1994-11-18 | 2002-04-30 | Neurocrine Biosciences, Inc. | Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein |
| AU721898B2 (en) * | 1994-11-18 | 2000-07-20 | Board Of Trustees Of The Leland Stanford Junior University | Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein |
| WO1996028470A2 (en) * | 1995-03-09 | 1996-09-19 | Neurocrine Biosciences, Inc. | Peptide analogues of human myelin basic protein useful in treating multiple sclerosis |
| CA2494338C (en) * | 1997-04-04 | 2007-07-17 | The Governors Of The University Of Alberta | Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
| WO2005009455A1 (fr) * | 2003-07-29 | 2005-02-03 | Terentiev Alexandr Alexandrovi | Composition de peptides presentant une propriete immunoregulatrice |
| AU2009354040A1 (en) * | 2009-10-12 | 2012-05-31 | Lifebio Laboratories Llc | Composition for treatment of Multiple Sclerosis |
| US9326773B2 (en) | 2012-01-26 | 2016-05-03 | Covidien Lp | Surgical device including buttress material |
| WO2024094562A1 (en) * | 2022-11-01 | 2024-05-10 | Universität Zürich | Novel mbp peptides and their use in the treatment of multiple sclerosis |
-
1991
- 1991-10-22 CA CA002053799A patent/CA2053799C/en not_active Expired - Lifetime
-
1992
- 1992-10-15 ES ES93908754T patent/ES2196007T3/es not_active Expired - Lifetime
- 1992-10-15 WO PCT/CA1992/000448 patent/WO1993008212A1/en active Search and Examination
- 1992-10-15 RU RU94027578A patent/RU2121850C1/ru not_active IP Right Cessation
- 1992-10-15 AU AU27500/92A patent/AU2750092A/en not_active Abandoned
- 1992-10-15 DK DK93908754T patent/DK0610446T3/da active
- 1992-10-15 EP EP93908754A patent/EP0610446B1/en not_active Expired - Lifetime
- 1992-10-15 AT AT93908754T patent/ATE236193T1/de not_active IP Right Cessation
- 1992-10-15 DE DE69232987T patent/DE69232987T2/de not_active Expired - Lifetime
- 1992-10-20 NZ NZ244807A patent/NZ244807A/xx not_active IP Right Cessation
-
1994
- 1994-04-19 NO NO19941415A patent/NO310513B1/no not_active IP Right Cessation
- 1994-04-21 FI FI941860A patent/FI111050B/fi active
Also Published As
| Publication number | Publication date |
|---|---|
| DE69232987T2 (de) | 2004-01-29 |
| ES2196007T3 (es) | 2003-12-16 |
| EP0610446B1 (en) | 2003-04-02 |
| NZ244807A (en) | 1997-08-22 |
| CA2053799C (en) | 2002-03-12 |
| NO310513B1 (no) | 2001-07-16 |
| ATE236193T1 (de) | 2003-04-15 |
| CA2053799A1 (en) | 1993-04-23 |
| NO941415D0 (no) | 1994-04-19 |
| AU2750092A (en) | 1993-05-21 |
| WO1993008212A1 (en) | 1993-04-29 |
| DE69232987D1 (de) | 2003-05-08 |
| RU2121850C1 (ru) | 1998-11-20 |
| FI941860A0 (fi) | 1994-04-21 |
| EP0610446A1 (en) | 1994-08-17 |
| NO941415L (no) | 1994-06-22 |
| FI941860A (fi) | 1994-04-21 |
| RU94027578A (ru) | 1996-10-20 |
| FI111050B (fi) | 2003-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0610446T3 (da) | Syntetisk peptidspecificitet af antimyelin basic protein fra cerebrospinalvæske fra dissemineret sklerose | |
| ATE108662T1 (de) | Antimikrobielle peptide, zusammensetzungen, die diese enthalten, und verwendungen daraus. | |
| ES2178000T3 (es) | Composiciones y metodos para tratar infecciones usando analogos de indolicidina. | |
| PT792287E (pt) | Analogos peptidicos da proteina basica da mielina humana | |
| DK0789709T3 (da) | Peptidspecificitet af anti-myelin basisprotein og administrationen af myelin basisproteinpeptider til dissemineret sklerose patienter | |
| AU7504096A (en) | Pseudomonas exotoxin - myelin basic protein chimeric proteins | |
| DE3586979D1 (de) | Neue zns-aktive peptide mit wirkung auf das cholinerge system. | |
| ATE356140T1 (de) | Gd3 mimetische peptide | |
| CY1107445T1 (el) | Θραυσματα πεπτιδιου βασικης πρωτεϊνης της μυελινης, οι φαρμακευτικες τους συνθεσεις και η χρηση τους στη θεραπεια της σκληρυνσης κατα πλακας | |
| NZ508812A (en) | Peptides for the prevention or treatment of HIV | |
| KR970074790A (ko) | 합성 펩티드를 함유하는 녹농균 백신 및 이것으로부터 생산된 치료제 | |
| NZ335835A (en) | Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |